An innovative cancer center making big strides in cancer immunotherapy
The University of Texas MD Anderson Cancer Center has emerged as a leader in cancer immunotherapy. Launched in 2012, the institution’s cancer Moon Shots Program, an ambitious effort to reduce cancer deaths and suffering by more rapidly developing advances based on scientific discoveries, includes a major emphasis on immunotherapy. With immune monitoring and scientific collaboration, the immunotherapy platform supports more than 100 clinical trials. The Parker Institute provides stable funding, access to cutting-edge technologies and an extended network of experts to help MD Anderson advance immunotherapy research to benefit cancer patients.